AI Strategy and Deployment in Life Sciences and Healthcare

Dr Indra Joshi has a unique portfolio of experience spanning data/AI strategy and implementation, whilst remaining true to her professional training as an emergency medic.  She is currently working across the global health and life sciences portfolio of Palantir Technologies to enable better use of data to impact health and care.

Dr. Joshi created the NHS AI Lab which led to the development and deployment of over 80 AI technologies into UK health and care, whilst determining the right ethical guidance and regulations to protect patients. As a former member of the World Health Organization Digital Health Technical Advisory Group, she was one of the of 20 globally renowned experts whose experience and knowledge are leveraged to support digital health programs and policy in the global healthcare ecosystem.

Alongside she is an associate editor for BMJ Leader, a Founding Member of One HealthTech – a volunteer network which exists to drive better equality, diversity and accessibility in health innovation; and most importantly a mum to two wonderful little munchkins.

Dr Michael Adeogun leads the Life Sciences and Health Challenge Area at the National Physical Laboratory (NPL). NPL is the UK’s National Measurement Institute working in partnership with government, academia, research laboratories, public sector, and industry to provide the required UK’s national measurement infrastructure. This includes supporting the development of trustworthy AI/ML and providing confidence in the use of data through its deep expertise in metrology (the science of measurement).

Director of Health Data Science at AstraZeneca, Dr Steven Kiddle uses real-world data (health records and insurance claims data) to optimise drug development. Prior to this Dr Kiddle was an MRC-sponsored group leader at the MRC Biostatistics Unit, University of Cambridge UK. His expertise is in real-world data, epidemiology, statistics, and prediction modelling. He also has experience supervising AI computational chemistry projects.

A co-founder at Isla, James managed Operations at Onfido, overseeing the annotation and labelling pipelines for the Computer Vision and AI that fuelled Onfido’s global growth story. James left Onfido to launch Isla in 2019 to keep patients safe at home through surfacing rich visual data for clinical review. He published a research study in collaboration with the Royal Brompton and Harefield Hospitals presenting Isla’s use of ML in blur detection for the capture of surgical wound images. Isla is quickly scaling across the NHS and is using Computer Vision and AI to tackle some key challenges where subtle clinical indicators in patient changes can have significant impact on patient health.

LinkedIn

Lara leads the AI for Digital Wound Surveillance project at Isla, where the team is building a model to detect early signs of infection in post-surgical wounds. Her background is in computational and medical physics and she has recently joined Isla to lead on experimental and research oriented projects. Lara’s role in this AI project is to ensure that the impact of real world factors are well understood and evaluated throughout.

LinkedIn

Anita is an Associate in Pinsent Masons’ Technology, Media and Telecoms practice. She routinely advises on IT contracts and data protection matters, with focus on the Life Sciences sector as well as other high-tech industries.